NEUP Neuphoria Therapeutics reports narrower than expected Q1 2026 loss shares climb 265 percent in todays trading THW abrdn quarterly earnings reflect managements optimistic longterm outlook for global healthcare investment opportunities CRBP Corbus posts narrower than expected Q4 2025 loss yet shares dip 157 percent in todays trading